According to Niagen Bioscience's latest financial reports the company's current EPS (TTM) is 0,12ย โฌ. In 2025 the company made an earnings per share (EPS) of 0,21ย โฌ an increase over its 2024 EPS that were of 0,09116ย โฌ.